Literature DB >> 26362407

Destabilization of the dimer interface is a common consequence of diverse ALS-associated mutations in metal free SOD1.

Helen R Broom1, Jessica A O Rumfeldt1, Kenrick A Vassall1, Elizabeth M Meiering1.   

Abstract

Neurotoxic misfolding of Cu, Zn-superoxide dismutase (SOD1) is implicated in causing amyotrophic lateral sclerosis, a devastating and incurable neurodegenerative disease. Disease-linked mutations in SOD1 have been proposed to promote misfolding and aggregation by decreasing protein stability and increasing the proportion of less folded forms of the protein. Here we report direct measurement of the thermodynamic effects of chemically and structurally diverse mutations on the stability of the dimer interface for metal free (apo) SOD1 using isothermal titration calorimetry and size exclusion chromatography. Remarkably, all mutations studied, even ones distant from the dimer interface, decrease interface stability, and increase the population of monomeric SOD1. We interpret the thermodynamic data to mean that substantial structural perturbations accompany dimer dissociation, resulting in the formation of poorly packed and malleable dissociated monomers. These findings provide key information for understanding the mechanisms and energetics underlying normal maturation of SOD1, as well as toxic SOD1 misfolding pathways associated with disease. Furthermore, accurate prediction of protein-protein association remains very difficult, especially when large structural changes are involved in the process, and our findings provide a quantitative set of data for such cases, to improve modelling of protein association.
© 2015 The Protein Society.

Entities:  

Keywords:  apo superoxide dismutase; dissociation thermodynamics; homodimer stability; isothermal titration calorimetry; protein-protein interactions

Mesh:

Substances:

Year:  2015        PMID: 26362407      PMCID: PMC4815230          DOI: 10.1002/pro.2803

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  57 in total

1.  The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis.

Authors:  Sagar D Khare; Michael Caplow; Nikolay V Dokholyan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-08       Impact factor: 11.205

2.  Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form.

Authors:  Aaron Kerman; Hsueh-Ning Liu; Sidney Croul; Juan Bilbao; Ekaterina Rogaeva; Lorne Zinman; Janice Robertson; Avijit Chakrabartty
Journal:  Acta Neuropathol       Date:  2010-01-29       Impact factor: 17.088

Review 3.  Heat capacity in proteins.

Authors:  Ninad V Prabhu; Kim A Sharp
Journal:  Annu Rev Phys Chem       Date:  2005       Impact factor: 12.703

4.  The essential dynamics of Cu, Zn superoxide dismutase: suggestion of intersubunit communication.

Authors:  G Chillemi; M Falconi; A Amadei; G Zimatore; A Desideri; A Di Nola
Journal:  Biophys J       Date:  1997-08       Impact factor: 4.033

5.  Mechanistic aspects of hSOD1 maturation from the solution structure of Cu(I) -loaded hCCS domain 1 and analysis of disulfide-free hSOD1 mutants.

Authors:  Lucia Banci; Francesca Cantini; Tatiana Kozyreva; Jeffrey T Rubino
Journal:  Chembiochem       Date:  2013-04-26       Impact factor: 3.164

6.  Many roads lead to Rome? Multiple modes of Cu,Zn superoxide dismutase destabilization, misfolding and aggregation in amyotrophic lateral sclerosis.

Authors:  Helen R Broom; Jessica A O Rumfeldt; Elizabeth M Meiering
Journal:  Essays Biochem       Date:  2014       Impact factor: 8.000

7.  Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants.

Authors:  Mikael J Lindberg; Roberth Byström; Niklas Boknäs; Peter M Andersen; Mikael Oliveberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-29       Impact factor: 11.205

8.  Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients.

Authors:  Karin Forsberg; P Andreas Jonsson; Peter M Andersen; Daniel Bergemalm; Karin S Graffmo; Magnus Hultdin; Johan Jacobsson; Roland Rosquist; Stefan L Marklund; Thomas Brännström
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

9.  SOD1-associated ALS: a promising system for elucidating the origin of protein-misfolding disease.

Authors:  Anna Nordlund; Mikael Oliveberg
Journal:  HFSP J       Date:  2008-10-14

10.  The threat of instability: neurodegeneration predicted by protein destabilization and aggregation propensity.

Authors:  Elizabeth M Meiering
Journal:  PLoS Biol       Date:  2008-07-29       Impact factor: 8.029

View more
  12 in total

1.  A misfolded dimer of Cu/Zn-superoxide dismutase leading to pathological oligomerization in amyotrophic lateral sclerosis.

Authors:  Itsuki Anzai; Eiichi Tokuda; Atsushi Mukaiyama; Shuji Akiyama; Fumito Endo; Koji Yamanaka; Hidemi Misawa; Yoshiaki Furukawa
Journal:  Protein Sci       Date:  2017-02-12       Impact factor: 6.725

2.  TNF receptor-associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation.

Authors:  Sabrina Semmler; Myriam Gagné; Pranav Garg; Sarah R Pickles; Charlotte Baudouin; Emeline Hamon-Keromen; Laurie Destroismaisons; Yousra Khalfallah; Mathilde Chaineau; Elise Caron; Andrew N Bayne; Jean-François Trempe; Neil R Cashman; Alexandra T Star; Arsalan S Haqqani; Thomas M Durcan; Elizabeth M Meiering; Janice Robertson; Nathalie Grandvaux; Steven S Plotkin; Heidi M McBride; Christine Vande Velde
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

3.  Probing the free energy landscapes of ALS disease mutants of SOD1 by NMR spectroscopy.

Authors:  Ashok Sekhar; Jessica A O Rumfeldt; Helen R Broom; Colleen M Doyle; Ryan E Sobering; Elizabeth M Meiering; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

4.  Trifluoroethanol Partially Unfolds G93A SOD1 Leading to Protein Aggregation: A Study by Native Mass Spectrometry and FPOP Protein Footprinting.

Authors:  Ben Niu; Brian C Mackness; Jill A Zitzewitz; C Robert Matthews; Michael L Gross
Journal:  Biochemistry       Date:  2020-09-21       Impact factor: 3.162

5.  Effects of maturation on the conformational free-energy landscape of SOD1.

Authors:  Robert M Culik; Ashok Sekhar; Jayashree Nagesh; Harmeen Deol; Jessica A O Rumfeldt; Elizabeth M Meiering; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-26       Impact factor: 11.205

6.  A Phosphomimetic Mutation Stabilizes SOD1 and Rescues Cell Viability in the Context of an ALS-Associated Mutation.

Authors:  James M Fay; Cheng Zhu; Elizabeth A Proctor; Yazhong Tao; Wenjun Cui; Hengming Ke; Nikolay V Dokholyan
Journal:  Structure       Date:  2016-09-22       Impact factor: 5.006

7.  Computing disease-linked SOD1 mutations: deciphering protein stability and patient-phenotype relations.

Authors:  Vijay Kumar; Safikur Rahman; Hani Choudhry; Mazin A Zamzami; Mohammad Sarwar Jamal; Asimul Islam; Faizan Ahmad; Md Imtaiyaz Hassan
Journal:  Sci Rep       Date:  2017-07-05       Impact factor: 4.379

8.  Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises.

Authors:  Luke McAlary; Yee Lian Chew; Jeremy Stephen Lum; Nicholas John Geraghty; Justin John Yerbury; Neil R Cashman
Journal:  Front Cell Neurosci       Date:  2020-11-04       Impact factor: 5.505

9.  Free energy calculations of ALS-causing SOD1 mutants reveal common perturbations to stability and dynamics along the maturation pathway.

Authors:  Nicholas G M Wells; Grant A Tillinghast; Alison L O'Neil; Colin A Smith
Journal:  Protein Sci       Date:  2021-06-22       Impact factor: 6.993

10.  Implications of fALS Mutations on Sod1 Function and Oligomerization in Cell Models.

Authors:  Aline A Brasil; Rayne S S Magalhães; Mariana D C De Carvalho; Isabel Paiva; Ellen Gerhardt; Marcos D Pereira; Tiago F Outeiro; Elis C A Eleutherio
Journal:  Mol Neurobiol       Date:  2017-09-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.